Adults taking the novel once-daily oral pill for plaque psoriasis have significantly higher rates of clear or almost clear ...

Steqeyma is indicated for the treatment of plaque psoriasis and psoriatic arthritis in adult and pediatric patients, as well ...

and adults with chronic moderate-to-severe plaque psoriasis. In clinical trials, the most common adverse effect of this treatment was injection site reaction (ISR). This can occur in up to 49% of ...

Some patients with psoriasis may have a super response to guselkumab, but questions remain regarding the generalizability of treatment strategies.

J&J's head of immunodermatology Liza O'Dowd said that the "robust results" with its oral IL-23 drug have the potential to ...

Celltrion has launched Steqeyma (ustekinumab-stba), its biosimilar of Stelara (ustekinumab), at list price at an 85% discount ...

Medicare coverage for psoriasis drugs depends on the type ... systemic oral drugs, biologic treatments, or injections. A formulary is a list of drugs that your plan covers. If your plan’s ...

Cheng said insurance considerations often come into play when deciding how to start psoriasis treatment ... she also uses direct injection of triamcinolone if the disease has not responded ...

Taltz (ixekizumab) is a prescription drug that’s used to treat certain autoimmune conditions such as psoriasis ... Taltz is given as an injection under the skin. Each dose of Taltz comes ...

Treatment typically includes a variety of topical, oral, and injectable medications. General pustular psoriasis (GPP ... The way the injection is given depends on whether the person is ...

STEQEYMA®, one of the first-wave biosimilars to STELARA®, is now available in the U.S.

Medicare coverage for psoriasis drugs depends on the type ... systemic oral drugs, biologic treatments, or injections. Medicare Part D prescription drug plan as an add-on to your Original Medicare ...